Autism Research and Treatment / 2012 / Article / Tab 4

Research Article

Safety and Observations in a Pilot Study of Lenalidomide for Treatment in Autism

Table 4

Individual clinical global impression ratings over the 12-week study period.

IDLanguage Expressive*Receptive Language*Social Skills*
BaselineWeek 6Week 12BaselineWeek 6Week 12BaselineWeek 6Week 12
66.0 4.06.0

𝑃 value*0.0420.0230.0270.0660.0660.066

*Decreasing scores reflect increased improvement.
𝑃 values represent the results of the differences between baseline values and 6 and 12-month values using the Wilcoxon Signed Ranks Test.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.